Page last updated: 2024-08-21

resazurin and Cholangiocarcinoma

resazurin has been researched along with Cholangiocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harada, Y; Hirai, H; Imanishi, J; Iwai, M; Kashima, K; Maruyama-Tabata, H; Mazda, O; Mori, T; Morikawa, T; Muramatsu, A; Okanoue, T; Satoh, E; Tanaka, S	1

Other Studies

1 other study(ies) available for resazurin and Cholangiocarcinoma

Article	Year
Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter. Cancer gene therapy, 2000, Volume: 7, Issue:9 Topics: beta-Galactosidase; Carcinoembryonic Antigen; Cell Survival; Cholangiocarcinoma; Colonic Neoplasms; Coloring Agents; DNA Primers; Epstein-Barr Virus Nuclear Antigens; Ganciclovir; Genetic Therapy; Genetic Vectors; Humans; Oxazines; Polyamines; Polymerase Chain Reaction; Promoter Regions, Genetic; Transfection; Tumor Cells, Cultured; Xanthenes	2000

Article

Year

Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.

Cancer gene therapy, 2000, Volume: 7, Issue:9

Topics: beta-Galactosidase; Carcinoembryonic Antigen; Cell Survival; Cholangiocarcinoma; Colonic Neoplasms; Coloring Agents; DNA Primers; Epstein-Barr Virus Nuclear Antigens; Ganciclovir; Genetic Therapy; Genetic Vectors; Humans; Oxazines; Polyamines; Polymerase Chain Reaction; Promoter Regions, Genetic; Transfection; Tumor Cells, Cultured; Xanthenes

2000